Richard Kremer

Dr. Richard Kremer

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Cancer Cell
Verified
Journal Article
Closed access
MCMarta Chesi
Marta Chesi
DRDavide F. Robbiani
Davide F. Robbiani
MSMichael Sebag
Michael Sebag
WCWee Joo Chng
Wee Joo Chng
MAMaurizio Affer
Maurizio Affer
PBP. Leif Bergsagel
P. Leif Bergsagel

24 March 2013 in Current Osteoporosis Reports
Verified
Journal Article
Open access
PDF file
ACAngela M. Cheung
Angela M. Cheung
JAJonathan D. Adachi
Jonathan D. Adachi
DHDavid A. Hanley
David A. Hanley
DKDavid L. Kendler
David L. Kendler
KDK. Shawn Davison
K. Shawn Davison
SBSteven Kyle Boyd
Steven Kyle Boyd
Bone structure is an integral determinant of bone strength. The availability of high resolution peripheral quantitative computed tomography (HR-pQCT) has made it possible to measure three-dimensional bone microarchitecture and volumetric bone mineral density in vivo, with accuracy previously unachievable and with relatively low-dose radiation. Recent studies using this novel imaging tool have increased our understanding of age-related changes and sex differences in bone microarchitecture, as well as the effect of different pharmacological therapies. One advantage of this novel tool is the use of finite element analysis modelling to non-invasively estimate bone strength and predict fractures using reconstructed three-dimensional images. In this paper, we describe the strengths and limitations of HR-pQCT and review the clinical studies using this tool.

1 January 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
RKRichard Kremer
Richard Kremer
PCPatricia P. Campbell
Patricia P. Campbell
TRTimothy Reinhardt
Timothy Reinhardt
VGVicente Gilsanz
Vicente Gilsanz
Context: Vitamin D insufficiency has now reached epidemic proportions and has been linked to low bone mineral density, increased risk of fracture, and obesity in adults. However, this relationship has not been well characterized in young adults. Objective: The objective of the study was to examine the relationship between serum 25-hydroxyvitamin D (25OHD), anthropometric measures, body fat (BF), and bone structure at the time of peak bone mass. Design: This was a cross-sectional study. Outcome Measures and Subjects: Anthropometric measures, serum 25OHD radioimmunoassay values, and computed tomography and dual-energy x-ray absorptiometry values of BF and bone structure in 90 postpubertal females, aged 16–22 yr, residing in California were measured. Results: Approximately 59% of subjects were 25OHD insufficient (≤29 ng/ml), and 41% were sufficient (≥30 ng/ml). Strong negative relationships were present between serum 25OHD and computed tomography measures of visceral and sc fat and dual-energy x-ray absorptiometry values of BF. In addition, weight, body mass, and imaging measures of adiposity at all sites were significantly lower in women with normal serum 25OHD concentrations than women with insufficient levels. In contrast, no relationship was observed between circulating 25OHD concentrations and measures of bone mineral density at any site. Unexpectedly, there was a positive correlation between 25OHD levels and height. Conclusions: We found that vitamin D insufficiency is associated with increased BF and decreased height but not changes in peak bone mass.

1 August 1989 in Endocrinology
Verified
Journal Article
Closed access
RKRichard Kremer
Richard Kremer
IBIsabel Bolivar
Isabel Bolivar
DGDavid Goltzman
David Goltzman
GHGeoffrey N. Hendy
Geoffrey N. Hendy
Exposure of quiescent bovine parathyroid cells to serum or a serum substitute caused an elevation in [3H] thymidine incorporation, followed by an increase in cell number. This was preceded by a rapid transient rise in c-myc and c-fos proto-oncogene mRNA levels. Alterations in the medium calcium concentration had no effect on the growth state of quiescent parathyroid cells. In addition, varying the medium calcium concentration did not influence either the time course or the degree of induction of proto-oncogene expression or the subsequent increase in [3H] thymidine uptake or proliferation of stimulated parathyroid cells. In contrast, when 1,25-dihydroxycholecalciferol was added with serum or serum substitute to quiescent parathyroid cells, no increase in c-myc mRNA levels was observed, and the expected increase in parathyroid cell number failed to occur. The augmentation in c-fos mRNA in response to serum was not, however, altered by 1,25-dihydroxycholecalciferol. These results indicate that 1,25-dihydroxyvitamin D, but not extracellular calcium, may directly modulate parathyroid cell proliferation by altering the expression of specific replication-associated oncogenes.

1 July 2009 in Clinical Biochemistry
Verified
Journal Article
Closed access
JBJacques P. Brown
Jacques P. Brown
CACaroline Albert
Caroline Albert
BNBassam A. Nassar
Bassam A. Nassar
JAJonathan D. Adachi
Jonathan D. Adachi
DCDavid Cole
David Cole
LSLouis-Georges Ste-Marie
Louis-Georges Ste-Marie

3 February 2011 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
Gustavo DuqueGustavo Duque
Gustavo Duque
DHDao Chao Huang
Dao Chao Huang
NDNatalie Dion
Natalie Dion
MMMichael Macoritto
Michael Macoritto
DRDaniel Rivas
Daniel Rivas
RKRichard Kremer
Richard Kremer
Interferon γ (IFN-γ) is a cytokine produced locally in the bone microenvironment by cells of immune origin as well as mesenchymal stem cells. However, its role in normal bone remodeling is still poorly understood. In this study we first examined the consequences of IFN-γ ablation in vivo in C57BL/6 mice expressing the IFN-γ receptor knockout phenotype (IFNγR1−/−). Compared with their wild-type littermates (IFNγR1+/+), IFNγR1−/− mice exhibit a reduction in bone volume associated with significant changes in cortical and trabecular structural parameters characteristic of an osteoporotic phenotype. Bone histomorphometry of IFNγR1−/− mice showed a low-bone-turnover pattern with a decrease in bone formation, a significant reduction in osteoblast and osteoclast numbers, and a reduction in circulating levels of bone-formation and bone-resorption markers. Furthermore, administration of IFN-γ (2000 and 10,000 units) to wild-type C57BL/6 sham-operated (SHAM) and ovariectomized (OVX) female mice significantly improved bone mass and microarchitecture, mechanical properties of bone, and the ratio between bone formation and bone resorption in SHAM mice and rescued osteoporosis in OVX mice. These data therefore support an important physiologic role for IFN-γ signaling as a potential new anabolic therapeutic target for osteoporosis. © 2011 American Society for Bone and Mineral Research.